Le Lézard
Classified in: Health, Business
Subject: TNM

Caresfield Acquires Chase Dental Supply


LAKEVILLE, Minn., Sept. 30, 2021 /PRNewswire/ -- Caresfield, LLC, a US-based manufacturer and distributor of healthcare consumable products such as labels and exam gloves, announces the acquisition of Chase Dental Supply. Chase Dental Supply was established in 2007, during a time of economic downturn for the country, with a goal to provide name-brand dental supplies and unique dental offerings from around the world to businesses in the United States at competitive prices. Today, the Chase Dental Supply portfolio includes a wide variety of consumable items, such as dental exam gloves, sutures, and cements, as well as bone management systems and laboratory products.

"We are excited about our expansion into the dental vertical under the Caresfield banner and feel Chase Dental Supply dovetails nicely into our operating model of providing consumable supplies at competitive prices to healthcare professionals across the nation," said Marty Griffith, Chairman and Co-Owner of Caresfield. "As the dental supply industry continues to expand and the nation's economy adapts to a new era, we feel it has become critical to adopt a different sales model that doesn't include the overhead or complexity of traditional dental supply companies, allowing us to pass along savings to customers while providing easy access to the products and brands they trust."

Chase Dental Supply will continue operations through its online store at www.chasedentalsupply.com. Additionally, products from the Caresfield portfolio, such as nitrile gloves, will now be offered through this online sales channel.

About Caresfield, LLC
For three decades, Caresfield has provided people-first support along with identification and specimen collection products for the healthcare industry. As a contracted vendor for many healthcare GPO's, Caresfield provides the cost savings, quick delivery, and reliability that today's healthcare providers look for in a trusted supply chain partner.

SOURCE Caresfield


These press releases may also interest you

at 08:20
Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that Dr. Stanley Appel, M.D., Chairman of Coya's Scientific Advisory...

at 08:05
Gilead Sciences, Inc. today announced the U.S. Food and Drug Administration (FDA) approved an updated label with additional data reinforcing the safety and efficacy profile of Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide...

at 08:05
Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (MDNAF: OTCQB), a clinical-stage immunotherapy company focused on the development of engineered cytokines, today announced a CA$20 million investment by RA Capital Management, a multi-stage...

at 08:02
Sobi® today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion recommending approval of efanesoctocog alfa, for the treatment and prevention of bleeds and perioperative...

at 08:00
Citius Pharmaceuticals Inc. ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced that it has entered into definitive...

at 08:00
Florida Cancer Specialists & Research Institute, LLC (FCS) President & Managing Physician Lucio N. Gordan, MD will serve as a panelist at the 2024 Oncology Fellows & Faculty Forum in Miami, sponsored by PrecisCa and the Community Oncology Alliance...



News published on and distributed by: